Pharmafile Logo
Pharmafocus logo
Advanced Search

opdivo

Showing 3 posts of 108 posts found.

BMS image

BMS therapeutic cancer vaccine given swift FDA appraisal

September 29, 2014
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, FDA, Vaccine, bristol myers-squibb, keytruda, melanoma, opdivo

Bristol-Myers Squibb has been granted a speedy review for its new cancer immunotherapy drug Opdivo by the FDA for patients …

News
BMS image

BMS to make Opdivo submission

July 11, 2014
Sales and Marketing BMS, Cancer, EMA, FDA, ono, opdivo, pd-1

Bristol-Myers Squibb is to submit cancer treatment Opdivo to the US authorities after the drug received its first approval in …

News
BMS image

World’s first anti-PD-1 therapy approved

July 8, 2014
Research and Development, Sales and Marketing BMS, Cancer, melanoma, nivolumab, ono, opdivo

Ono Pharmaceutical has been given the world’s first licence for a new type of cancer treatment on which many researchers’ …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026